|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's range||70.87 - 73.18|
|52-week range||61.28 - 101.24|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||N/A|
|Earnings date||02 Aug 2022 - 08 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||118.33|
Bayer (BAYRY) beats estimates for both earnings and revenues in the first quarter of 2022.
Quite a few insiders have dramatically grown their holdings in Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) over the past...
Strong demand for Sarepta's (SRPT) DMD drugs boosts its top line in the first quarter. Stock up in after-market trading.